AR and prostate carcinoma: Indeed, prostate cancer chemotherapeutics such as docetaxel function by stabilising microtubules, leading to mitotic arrest and apoptosis of cancer cells, in addition to inhibiting translocation of the oncogenic androgen receptor (AR) to the nucleus [201,202].